Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jimena Alba is active.

Publication


Featured researches published by Jimena Alba.


Antimicrobial Agents and Chemotherapy | 2005

Kinetics study of KPC-3, a plasmid-encoded class a carbapenem-hydrolyzing beta-lactamase

Jimena Alba; Yoshikazu Ishii; Kenneth S. Thomson; Ellen Smith Moland; Keizo Yamaguchi

ABSTRACT The kinetic activity of KPC-3, a plasmid-encoded class A carbapenemase, was studied. It hydrolyzed penicillins, cephalosporins, carbapenems, and even sulbactam. The best substrate was cephalothin (kcat/Km = 3.48 μM−1 s−1). The efficiency of the enzyme was similar for imipenem and meropenem (kcat/Km, 1.4 and 1.94 μM−1 s−1, respectively).


Journal of Clinical Microbiology | 2005

Extended-Spectrum β-Lactamase-Producing Shiga Toxin Gene (stx1)-Positive Escherichia coli O26:H11: a New Concern

Yoshikazu Ishii; Soichiro Kimura; Jimena Alba; Katsuaki Shiroto; Masanobu Otsuka; Naotaka Hashizume; Kazumichi Tamura; Keizo Yamaguchi

ABSTRACT Escherichia coli strain TUM2139 was isolated from a stool sample from a 9-year-old girl on 16 June 2004. This strain was categorized as Shiga toxin-producing Escherichia coli (STEC) because the Shiga-like toxin gene stx1 was detected by immunochromatography and PCR assay. The strain was highly resistant to cefotaxime (256 μg/ml) and was also resistant to cefepime, cefpodoxime, ceftriaxone, and aztreonam. In the presence of 4 μg of clavulanic acid per ml, the MIC of cefotaxime decreased to ≤0.12 μg/ml, indicating that this strain was an extended-spectrum β-lactamase (ESBL) producer. Cefotaxime resistance was transferred to E. coli C600 by conjugation at a frequency of 3.0 × 10−6. A PCR assay was performed with primer sets specific for TEM-type and SHV-type ESBLs and for the CTX-M-2 (Toho-1), CTX-M-3, and CTX-M-9 groups of ESBLs. A specific signal was observed with the primer set specific for the CTX-M-9 group of β-lactamases. This β-lactamase was confirmed to be the ESBL CTX-M-18 by DNA sequencing. This is the first report of an ESBL-producing STEC isolate.


Journal of Clinical Microbiology | 2005

Clonal Diversity of Metallo-β-Lactamase-Possessing Pseudomonas aeruginosa in Geographically Diverse Regions of Japan

Soichiro Kimura; Jimena Alba; Katsuaki Shiroto; Reiko Sano; Yoshihito Niki; Shigefumi Maesaki; Koji Akizawa; Mitsuo Kaku; Yuji Watanuki; Yoshikazu Ishii; Keizo Yamaguchi

ABSTRACT The aim of this study was to determine the distribution of metallo-β-lactamase-producing Pseudomonas aeruginosa in Japan and to investigate the molecular characteristics of resistance gene cassettes including the gene encoding this enzyme. A total of 594 nonduplicate strains of P. aeruginosa isolated from 60 hospitals throughout Japan in 2002 were evaluated. This study indicated that although the prevalence of imipenem-resistant P. aeruginosa has not increased compared to that found in previous studies, clonal distribution of the same strain across Japan is evident.


Antimicrobial Agents and Chemotherapy | 2004

Role of a Mutation at Position 167 of CTX-M-19 in Ceftazidime Hydrolysis

Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi

ABSTRACT CTX-M-19 is a recently identified ceftazidime-hydrolyzing extended-spectrum β-lactamase, which differs from the majority of CTX-M-type β-lactamases that preferentially hydrolyze cefotaxime but not ceftazidime. To elucidate the mechanism of ceftazidime hydrolysis by CTX-M-19, the β-lactam MICs of a CTX-M-19 producer, and the kinetic parameters of the enzyme were confirmed. We reconfirmed here that CTX-M-19 is also stable at a high enzyme concentration in the presence of bovine serum albumin (20 μg/ml). Under this condition, we obtained more accurate kinetic parameters and determined that cefotaxime (kcat/Km, 1.47 × 106 s−1 M−1), cefoxitin (kcat/Km, 62.2 s−1 M−1), and aztreonam (kcat/Km, 1.34 × 103 s−1 M−1) are good substrates and that imipenem (k+2/K, 1.20 × 102 s−1 M−1) is a poor substrate. However, CTX-M-18 and CTX-M-19 exhibited too high a Km value (2.7 to 5.6 mM) against ceftazidime to obtain their catalytic activity (kcat). Comparison of the MICs with the catalytic efficiency (kcat/Km) of these enzymes showed that some β-lactams, including cefotaxime, ceftazidime, and aztreonam showed a similar correlation. Using the previously reported crystal structure of the Toho-1 β-lactamase, which belongs to the CTX-M-type β-lactamase group, we have suggested characteristic interactions between the enzymes and the β-lactams ceftazidime, cefotaxime, and aztreonam by molecular modeling. Aminothiazole-bearing β-lactams require a displacement of the aminothiazole moiety due to a severe steric interaction with the hydroxyl group of Ser167 in CTX-M-19, and the displacement affects the interaction between Ser130 and the acidic group such as carboxylate and sulfonate of β-lactams.


Antimicrobial Agents and Chemotherapy | 2005

Kinetic properties of four plasmid-mediated AmpC beta-lactamases.

Cédric Bauvois; Akiko Ibuka; Almeida Celso; Jimena Alba; Yoshikazu Ishii; Jean-Marie Frère; Moreno Galleni

ABSTRACT The heterologous production in Escherichia coli, the purification, and the kinetic characterization of four plasmid-encoded class C β-lactamases (ACT-1, MIR-1, CMY-2, and CMY-1) were performed. Except for their instability, these enzymes are very similar to the known chromosomally encoded AmpC β-lactamases. Their kinetic parameters did not show major differences from those obtained for the corresponding chromosomal enzymes. However, the Km values of CMY-2 for cefuroxime, cefotaxime, and oxacillin were significantly decreased compared to those of the chromosomal AmpC enzymes. Finally, the susceptibility patterns of different E. coli hosts producing a plasmid- or a chromosome-encoded class C enzyme toward β-lactam antibiotics are mainly due to the overproduction of the β-lactamase in the periplasmic space of the bacteria rather than to a specific catalytic profile of the plasmid-encoded β-lactamases.


Antimicrobial Agents and Chemotherapy | 2005

Novel SHV-Derived Extended-Spectrum β-Lactamase, SHV-57, That Confers Resistance to Ceftazidime but Not Cefazolin

Ling Ma; Jimena Alba; Feng-Yee Chang; Masaji Ishiguro; Keizo Yamaguchi; L. K. Siu; Yoshikazu Ishii

ABSTRACT A new SHV-derived extended-spectrum β-lactamase, SHV-57, that confers high-level resistance to ceftazidime but not cefotaxime or cefazolin was identified from a national surveillance study conducted in Taiwan in 1998. An Escherichia coli isolate resistant to ampicillin, cephalothin, and ceftazidime but sensitive to cefoxitin, ceftriaxone, cefotaxime, imipenem, and a narrow-spectrum cephem (cefazolin) was isolated from the urine of a patient treated with β-lactam antibiotics. Resistance to β-lactams was conjugatively transferred with a plasmid of about 50 kbp. The pI of this enzyme was 8.3. The sequence of the gene was determined, and the open reading frame of the gene was found to consist of 861 bases (GenBank accession number AY223863 ). Kinetic parameters showed that SHV-57 had a poor affinity to cefazolin. The Km value toward cefazolin (5.57 × 103 μM) was extremely high in comparison to those toward ceftazidime (30.9 μM) and penicillin G (67 μM), indicating its low affinity to cefazolin. Although the Km value of the β-lactamase inhibitor was too high for the study of catalytic activity (kcat), indicating the low kcat of SHV-57, the SHV-57 carrier was highly susceptible to a β-lactam-β-lactamase inhibitor combination. Comparison of the three-dimensional molecular model of SHV-57 with that of the SHV-1 β-lactamase suggests that the substitution of arginine for leucine-169 in the Ω loop is important for the substrate specificity.


Fems Microbiology Letters | 2003

A detailed kinetic study of Mox-1, a plasmid-encoded class C β-lactamase

Jimena Alba; Cédric Bauvois; Yoshikazu Ishii; Moreno Galleni; Katsuyoshi Masuda; Masaji Ishiguro; Masahiko Ito; Jean-Marie Frère; Keizo Yamaguchi

Abstract Surveys of β-lactamases in different parts of the world show an important increase in class C β-lactamases, thus the study of these enzymes is becoming an important issue. We created an overproduction system for Mox-1, a plasmid class C β-lactamase, by cloning the gene encoding this enzyme, and placing it under the control of a T7 promoter, using vector pET 28a. The enzyme, purified by ion exchange chromatography, was used to obtain the molecular mass (38 246), the N-terminal sequence (GEASPVDPLRPVV), and p I (8.9), and to perform a detailed kinetic study. Cephalotin was used as reporter substrate in the case of poor substrates. The kinetic study showed that benzylpenicillin, cephalotin, cefcapene and moxalactam were good substrates for Mox-1 ( k cat / K m values >2.5 ×10 6 M −1 s −1 ). On the other hand, ceftazidime and cefepime were poor substrates for this enzyme ( K m values >200 μM). Clavulanic acid had no inhibitory effect on Mox-1 ( K m =30.2 mM), however aztreonam behaved as an inhibitor of Mox-1 ( K i =2.85 μM).


International Journal of Antimicrobial Agents | 2007

Nosocomial outbreak of genetically related IMP-1 β-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan

Shinako Fukigai; Jimena Alba; Soichiro Kimura; Toshie Iida; Noriko Nishikura; Yoshikazu Ishii; Keizo Yamaguchi


Diagnostic Microbiology and Infectious Disease | 2006

Evaluation of antimicrobial activity of β-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004)

Yoshikazu Ishii; Jimena Alba; Soichiro Kimura; Keizo Yamaguchi


Journal of Medical Microbiology | 2005

Metallo-β-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan

Katsuaki Shiroto; Yoshikazu Ishii; Soichiro Kimura; Jimena Alba; Kiwao Watanabe; Yoshiko Matsushima; Keizo Yamaguchi

Collaboration


Dive into the Jimena Alba's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masaji Ishiguro

Niigata University of Pharmacy and Applied Life Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge